Literature DB >> 8023276

Subungual melanoma: an eighteen-year review.

R K Finley1, D L Driscoll, L E Blumenson, C P Karakousis.   

Abstract

BACKGROUND: Subungual melanoma is a rare lesion comprising 1% to 3% of all melanoma cases.
METHODS: Records of twenty-two patients with subungual melanoma treated at Roswell Park Cancer Institute during the period September 1971 to September 1989 were reviewed in a retrospective manner. Most common sites of involvement were the great toe on the foot (n = 7), the thumb (n = 4), and the index (n = 3) and ring fingers (n = 3) on the hand. Common signs included pigmentation of the nail bed, nail loss, and nail destruction.
RESULTS: Thickness of the lesion could be determined in 10 patients. All four patients with lesions 1.0 mm and thinner at the time of biopsy were alive and disease free at 19, 20, 55, and 78 months, whereas three of six patients with lesions thicker than 1.0 mm were dead at 15, 51, and 56 months. Patients with ulcerated lesions had an estimated 5-year survival rate of 39% as compared with 80% for the group without ulceration. Seven patients underwent finger amputations distal to the metacarpophalangeal joint, and none experienced local recurrence. Four amputations were just proximal to the distal interphalangeal joint, and three were just proximal to the proximal interphalangeal joint. One of these patients died of metastatic melanoma at 56 months, and the other six were alive and disease free at 13, 19, 20, 32, 72, and 78 months from the time of diagnosis.
CONCLUSIONS: More distal amputations of subungual melanomas of the hand preserve function and do not compromise survival or local control.

Entities:  

Mesh:

Year:  1994        PMID: 8023276

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

1.  Subungual acrolentiginous amelanotic melanoma treated with amputation of the distal and middle phalanges.

Authors:  Claudio Guarneri; Valentina Bevelacqua; Kristina Semkova; Georgi Tchernev; Sven Tempel; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2013-04-17

Review 2.  Primary Melanoma: from History to Actual Debates.

Authors:  Alessandro A E Testori; Stephanie A Blankenstein; Alexander C J van Akkooi
Journal:  Curr Oncol Rep       Date:  2019-12-19       Impact factor: 5.075

3.  A survey-based study of management of longitudinal melanonychia amongst attending and resident dermatologists.

Authors:  Pierre Halteh; Richard Scher; Amanda Artis; Shari R Lipner
Journal:  J Am Acad Dermatol       Date:  2017-05       Impact factor: 11.527

Review 4.  Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma--Part I.

Authors:  Luiz Guilherme Martins Castro; Maria Cristina Messina; Walter Loureiro; Ricardo Silvestre Macarenco; João Pedreira Duprat Neto; Thais Helena Bello Di Giacomo; Flávia Vasques Bittencourt; Renato Marchiori Bakos; Sérgio Schrader Serpa; Hamilton Ometto Stolf; Gabriel Gontijo
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

5.  Assessment of Patient Knowledge of Longitudinal Melanonychia: A Survey Study of Patients in Outpatient Clinics.

Authors:  Pierre Halteh; Richard Scher; Amanda Artis; Shari Lipner
Journal:  Skin Appendage Disord       Date:  2016-11-09

6.  Melanonychia.

Authors:  Julie Jefferson; Phoebe Rich
Journal:  Dermatol Res Pract       Date:  2012-06-27

7.  Surgery of primary melanomas.

Authors:  Piotr Rutkowski; Marcin Zdzienicki; Zbigniew I Nowecki; Alexander C J Van Akkooi
Journal:  Cancers (Basel)       Date:  2010-05-11       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.